used to treat
seizures and infantile spasms. Sabril has the potential to cause vision loss, so it is part of a Risk Evaluation and Mitigation Strategy (REMS) Program by the FDA. This means that patients need
to go through certified prescribers to access the medication. Patients typically take 180 tablets per month
